Institute of Chengdu Biology, Chinese Academy of Sciences, Chengdu, China.
Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Clin Exp Ophthalmol. 2020 Apr;48(3):356-365. doi: 10.1111/ceo.13690. Epub 2019 Dec 6.
Familial exudative vitreoretinopathy (FEVR, OMIM 133780) is a severe hereditary retinal disease characterized by incomplete retinal vascular development and pathological neovascularization. It has been reported that variants in nine genes are associated with FEVR, but they can only explain approximately 50% of FEVR patients, suggesting that other FEVR-associated variants or genes remain to be discovered.
Whole-exome sequencing (WES) was carried out to analyse genomic DNA samples from the probands of 68 families with FEVR. Sanger sequencing was used to verify all identified variants. Western blot analysis was utilized to detect the expression of the variant mutant proteins. A luciferase assay was conducted to test the receptor activity of the mutant FZD4 proteins in Norrin-β-catenin signaling.
Seven heterozygous FZD4 variants were found to cause FEVR in seven families, including six missense variants and one deletion variant: c.182C>T (p.T61I), c.205C>T (p.H69Y), c.217_234del (p.73T_78Qdel), c.264C>A (p.Y88X), c.344G>T (p.G115V), c.678G>A (p.W226X) and c.1310T>C (p.I437T). Among these variants, c.205C>T (p.H69Y) and c.678G>A (p.W226X) are known FEVR-causing variants, while the other five variants are novel pathogenic variants.
Our study revealed the cause of FEVR in seven Chinese families and identified five novel pathogenic variants in FZD4, which expanded the mutation spectrum of FEVR in the Chinese population. These findings also provided further support for using WES in the clinical diagnosis of FEVR.
家族性渗出性玻璃体视网膜病变(FEVR,OMIM 133780)是一种严重的遗传性视网膜疾病,其特征为视网膜血管发育不完全和病理性新生血管形成。据报道,有九个基因的变异与 FEVR 相关,但它们只能解释大约 50%的 FEVR 患者,这表明还有其他与 FEVR 相关的变异或基因有待发现。
对 68 个 FEVR 家系的先证者基因组 DNA 样本进行全外显子组测序(WES)。应用 Sanger 测序对所有鉴定的变异进行验证。采用 Western blot 分析检测变异型 FZD4 蛋白的表达。利用荧光素酶报告基因检测法检测突变 FZD4 蛋白在 Norrin-β-catenin 信号通路中的受体活性。
在七个家系中发现七个杂合性 FZD4 变异导致 FEVR,包括六个错义变异和一个缺失变异:c.182C>T(p.T61I)、c.205C>T(p.H69Y)、c.217_234del(p.73T_78Qdel)、c.264C>A(p.Y88X)、c.344G>T(p.G115V)、c.678G>A(p.W226X)和 c.1310T>C(p.I437T)。其中 c.205C>T(p.H69Y)和 c.678G>A(p.W226X)是已知的 FEVR 致病变异,而其他五个变异是新的致病性变异。
本研究揭示了七个中国家系 FEVR 的病因,并在 FZD4 中发现了五个新的致病性变异,扩大了中国人群中 FEVR 的突变谱。这些发现也为 WES 在 FEVR 的临床诊断中的应用提供了进一步的支持。